Skip to main content

Table 5 Characteristics of FD patients hospitalized for COVID-19 infection

From: The impact of the COVID-19 pandemic on Fabry Disease Patients: an examination of Mood Status, Therapy Adherence, and COVID-19 infection

 

#1

#2

#3

#4

#5

Age

45

36

42

65

54

Gender

M

M

M

F

M

Fabry phenotype

Classic

Classic

Classic

Classic

Classic

Fabry-related risk factor

LVH, Kidney tx

LVH, stroke

LVH, stroke

LVH, stroke

LVH, stroke

ERT

Yes

Yes

Yes

Yes

Yes

COVID-19 related variables

 Symptoms

Fever, cough, dyspnea, myalgias

Cough, myalgias, diarrhea

Cough, headache

Fever, cough, dyspnea

Fever, cough, dyspnea, ageusia and anosmia

 Disease severity*

Severe

Moderate

Moderate

Moderate

Critical

 Treatment

Favipiravir, Corticosteroid LMWH

Favipiravir, LMWH

Favipiravir, LMWH

Favipiravir, LMWH

Favipiravir, Corticosteroid LMWH

 Vaccination status

No

No

No

No

No

 Outcome

Recovered

Recovered

Recovered

Recovered

Died

  1. ERT, Enzyme replacement therapy; M, Male; F, Female; Kidney tx, Kidney transplantation; LVH, Left ventricular hypertrophy; LMWH, Low-molecular weight heparin
  2. *Disease severity was classified according to reference 16